Show
Sort by
-
- Journal Article
- A1
- open access
Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases
-
- Journal Article
- A1
- open access
Management of anaphylaxis due to COVID‐19 vaccines in the elderly
-
Development of the International Severe Asthma Registry (ISAR) : a modified Delphi study
-
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52) : results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
-
Next-generation care pathways for allergic rhinitis and asthma multimorbidity : a model for multimorbid non-communicable diseases : meeting report (part 2)
-
International consensus statement on allergy and rhinology : allergic rhinitis
-
Allergic rhinitis and its impact on asthma (ARIA) guidelines : 2016 revision
-
- Journal Article
- A1
- open access
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
-
- Journal Article
- A1
- open access
The hidden burden of adult allergic rhinitis : UK healthcare resource utilisation survey
-
- Journal Article
- A1
- open access
A common language to assess allergic rhinitis control : results from a survey conducted during EAACI 2013 congress
-
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps
-
Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis
-
SIT: efficacy depends on product, not on route of application
-
Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis
-
Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review